PU.1 inhibition sensitizes stem-monocytic AML to BCL2 blockade.

Saved in:
Bibliographic Details
Title: PU.1 inhibition sensitizes stem-monocytic AML to BCL2 blockade.
Authors: Yashar WM; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; These authors contributed equally to this work. For CV and publication listings, both authors may designate themselves as the first author., Pacentine IV; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; These authors contributed equally to this work. For CV and publication listings, both authors may designate themselves as the first author., Taherinasab A; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA., Nguyen T; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA., Worme S; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA., Tsuchiya M; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA., Lusardi T; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; Cancer Early Detection Advanced Research Center, Oregon Health & Science University; Portland, OR, 97239, USA., Hutchinson C; Biological Sciences Division, Pacific Northwest National Laboratory, Richland WA., Fillmore TL; Environmental and Molecular Sciences Division, Pacific Northwest National Laboratory, Richland WA., Posso C; Biological Sciences Division, Pacific Northwest National Laboratory, Richland WA., Gosline SJ; Biological Sciences Division, Pacific Northwest National Laboratory, Richland WA., Piehowski PD; Environmental and Molecular Sciences Division, Pacific Northwest National Laboratory, Richland WA., Yardimci GG; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; Cancer Early Detection Advanced Research Center, Oregon Health & Science University; Portland, OR, 97239, USA., Adey AC; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; Biological Sciences Division, Pacific Northwest National Laboratory, Richland WA.; Environmental and Molecular Sciences Division, Pacific Northwest National Laboratory, Richland WA., Maxson JE; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Cell Developmental & Cancer Biology, Oregon Health & Science University; Portland, OR, 97239, USA., Braun TP; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University; Portland, OR, 97239, USA.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University; Portland, OR, 97239, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Jan 23. Date of Electronic Publication: 2026 Jan 23.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.01.20.700677